Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE)

• Company Description    Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. Number of Employees: 2,442

• Price / Volume Information    Yesterday's Closing Price: $27.71 Daily Weekly Monthly 20 Day Moving Average: 9,841,422 shares Shares Outstanding: 233.31 (millions) Market Capitalization: $6,465.10 (millions) Beta: 2.44 52 Week High: $50.99 52 Week Low: $13.74 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.36% -4.36% 12 Week 2.48% -0.02% Year To Date -14.66% -19.86%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2269 CHESTNUT STREET SUITE 523 - SAN FRANCISCO,CA 94123 USA ph: 415-851-0195 fax: - investors@forhims.com http://www.hims.com

• General Corporate Information    Officers Andrew Dudum - Chief Executive Officer Oluyemi Okupe - Chief Financial Officer Irene Becklund - Chief Accounting Officer Delos Cosgrove - Director Anja Manuel - Director Peer Information Hims & Hers Health, Inc. (HLIS) Hims & Hers Health, Inc. (AZTA) Hims & Hers Health, Inc. (APYI) Hims & Hers Health, Inc. (RNVA) Hims & Hers Health, Inc. (HMSY) Hims & Hers Health, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 433000106 SIC: 8011 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/09/26 Share - Related Items Shares Outstanding: 233.31 Most Recent Split Date: (:1) Beta: 2.44 Market Capitalization: $6,465.10 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.08 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.16 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 31.89% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/09/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 19.95 Price/Cash Flow: 33.11 Price / Sales: 2.51 EPS Growth vs. Year Ago Period: -158.82% vs. Previous Quarter: 44.44% Sales Growth vs. Year Ago Period: 38.25% vs. Previous Quarter: 23.86% ROE 09/30/26 - - 06/30/26 - -6.51 03/31/26 - 6.10 ROA 09/30/26 - - 06/30/26 - -1.20 03/31/26 - 1.52 Current Ratio 09/30/26 - - 06/30/26 - 0.93 03/31/26 - 1.69 Quick Ratio 09/30/26 - - 06/30/26 - 0.87 03/31/26 - 1.56 Operating Margin 09/30/26 - - 06/30/26 - -1.19 03/31/26 - 1.37 Net Margin 09/30/26 - - 06/30/26 - -5.51 03/31/26 - -0.56 Pre-Tax Margin 09/30/26 - - 06/30/26 - -6.35 03/31/26 - -1.61 Book Value 09/30/26 - - 06/30/26 - 1.39 03/31/26 - 1.93 Inventory Turnover 09/30/26 - - 06/30/26 - 9.22 03/31/26 - 6.59 Debt-to-Equity 09/30/26 - - 06/30/26 - 4.21 03/31/26 - 2.18 Debt-to-Capital 09/30/26 - - 06/30/26 - 80.82 03/31/26 - 68.59

Powered by Zacks Investment Research ©